Nurse Intervention Using Tech May Improve PID Care in Youth
WEDNESDAY, Aug. 7, 2019 -- Adolescent and young adult women with pelvic inflammatory disease (PID) are more likely to experience decreases in Neisseria gonorrhoeae and Chlamydia trachomatis positivity with a technology-enhanced community health nursing (TECH-N) intervention, according to a study published online Aug. 7 in JAMA Network Open.
Maria Trent, M.D., M.P.H., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the efficacy of a TECH-N intervention versus standard of care for improving PID self-management behaviors and prevalence of N. gonorrhoeae and C. trachomatis. Female patients aged 13 to 25 years of age diagnosed with mild-to-moderate PID were randomly assigned to either standard treatment (137 participants) or the TECH-N intervention (149 participants).
The researchers found that N. gonorrhoeae and C. trachomatis positivity did not differ significantly between the intervention and control groups at 90-day follow-up (4.4 and 10.4 percent, respectively; P = 0.07); however, the intervention group had a significantly higher differential rate of decrease (34.4 versus 4.4 percent compared with 25.6 versus 10.4 percent; P = 0.02). Compared with the control group, intervention participants were significantly more likely to receive the U.S. Centers for Disease Control and Prevention-recommended short-term follow-up visit (94.2 versus 16.3 percent; P < 0.001).
"The TECH-N intervention showed sufficient success for delivery of the CDC recommendations for interim care and short-term reduction in sexually transmitted infection acquisition and should be considered as a potential enhancement of standard of care approaches," the authors write.
Several authors disclosed financial ties to the biopharmaceutical and medical device industries.
© 2020 HealthDay. All rights reserved.
Posted: August 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.